Literature DB >> 22993412

Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Marcela F Pasetti1, Myron M Levine.   

Abstract

Year:  2012        PMID： 22993412      PMCID： PMC3491553          DOI： 10.1128/CVI.00543-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


× No keyword cloud information.
  52 in total

1.  Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

2.  Nomenclature for immune correlates of protection after vaccination.

Authors:  Stanley A Plotkin; Peter B Gilbert
Journal:  Clin Infect Dis       Date:  2012-03-20       Impact factor: 9.079

Review 3.  Oral vaccines against cholera.

Authors:  Sunheang Shin; Sachin N Desai; Binod K Sah; John D Clemens
Journal:  Clin Infect Dis       Date:  2011-04-14       Impact factor: 9.079

4.  Enteric infections in an endemic area induce a circulating antibody-secreting cell response with homing potentials to both mucosal and systemic tissues.

Authors:  F Qadri; P H Mäkelä; J Holmgren; M J Albert; K Mannoor; A Kantele; D Saha; M A Salam; J M Kantele
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

Review 5.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

6.  A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

7.  Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans.

Authors:  Alison Kuchta; Taibur Rahman; Erica L Sennott; Taufiqur R Bhuyian; Taher Uddin; Rasheduzzaman Rashu; Fahima Chowdhury; Ashraf I Kahn; Mohammad Arifuzzaman; Ana A Weil; Michael Podolsky; Regina C LaRocque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

8.  Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; M Asrafuzzaman Riyadh; Sweta M Patel; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Eric J Kalivoda; Amena Aktar; M Saruar Bhuiyan; Regina C LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

Review 9.  Enteric infections and the vaccines to counter them: future directions.

Authors:  Myron M Levine
Journal:  Vaccine       Date:  2006-03-24       Impact factor: 3.641

10.  Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.

Authors:  Rezwanul Wahid; Raphael Simon; Shah J Zafar; Myron M Levine; Marcelo B Sztein
Journal:  Clin Vaccine Immunol       Date:  2012-04-04
View more
  12 in total

1.  Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Authors:  Kara J Levinson; Magdia De Jesus; Nicholas J Mantis
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

2.  Wading Into the Morass: Natural Immunity to Enteropathogens.

Authors:  Benjamin A Lopman; Julia M Baker
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

3.  Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.

Authors:  Kara J Levinson; Samantha R Giffen; Michael H Pauly; Do H Kim; Ognian Bohorov; Natasha Bohorova; Kevin J Whaley; Larry Zeitlin; Nicholas J Mantis
Journal:  J Immunol Methods       Date:  2015-04-09       Impact factor: 2.303

Review 4.  Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.

Authors:  Shahjahan Kabir
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

5.  Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.

Authors:  Wilbur H Chen; Mitchell B Cohen; Beth D Kirkpatrick; Rebecca C Brady; David Galloway; Marc Gurwith; Robert H Hall; Robert A Kessler; Michael Lock; Douglas Haney; Caroline E Lyon; Marcela F Pasetti; Jakub K Simon; Flora Szabo; Sharon Tennant; Myron M Levine
Journal:  Clin Infect Dis       Date:  2016-03-21       Impact factor: 9.079

6.  Antibody-mediated inhibition of ricin toxin retrograde transport.

Authors:  Anastasiya Yermakova; Tove Irene Klokk; Richard Cole; Kirsten Sandvig; Nicholas J Mantis
Journal:  mBio       Date:  2014-04-08       Impact factor: 7.867

7.  Immunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera.

Authors:  Gregory A Price; Randall K Holmes
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

8.  Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination.

Authors:  Danielle E Baranova; Kara J Levinson; Nicholas J Mantis
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

9.  Protection From Natural Immunity Against Enteric Infections and Etiology-Specific Diarrhea in a Longitudinal Birth Cohort.

Authors:  Elizabeth T Rogawski McQuade; Jie Liu; Gagandeep Kang; Margaret N Kosek; Aldo A M Lima; Pascal O Bessong; Amidou Samie; Rashidul Haque; Estomih R Mduma; Sanjaya Shrestha; Jose Paulo Leite; Ladaporn Bodhidatta; Najeeha Iqbal; Nicola Page; Ireen Kiwelu; Zulfiqar Bhutta; Tahmeed Ahmed; Eric R Houpt; James A Platts-Mills
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

10.  Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks.

Authors:  Krystal Teasley Hamorsky; J Calvin Kouokam; Lauren J Bennett; Keegan J Baldauf; Hiroyuki Kajiura; Kazuhito Fujiyama; Nobuyuki Matoba
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.